The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 22, 2022

Filed:

Apr. 01, 2022
Applicant:

Achilles Therapeutics Uk Limited, London, GB;

Inventors:

Andrew Roth, Oxford, GB;

Maximilian Prinz Zu Salm-Horstmar, London, GB;

Fong Chun Chan, London, GB;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); G16B 30/10 (2019.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01); G16H 20/10 (2018.01); C12Q 1/6886 (2018.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 39/0011 (2013.01); A61P 35/00 (2018.01); C12Q 1/6886 (2013.01); G16B 30/10 (2019.02); G16H 20/10 (2018.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01);
Abstract

A method of treating a subject having been diagnosed as having cancer with an immunotherapy is described. The method comprises targeting one or more clonal neoantigens selected using a method comprising determining whether a tumour-specific mutation is likely to be clonal in a subject. The method comprises providing sequence data from one or more samples from the subject comprising tumour genetic material, the sequence data comprising for each of the one or more samples, and determining the likelihood that the tumour-specific mutation is clonal as a posterior probability depending on: a prior probability of the mutation being clonal, and the probabilities of observing the sequence data if the tumour-specific mutation is (i) clonal and (ii) non-clonal, in view of a tumour fraction for each of the one or more samples and one or more candidate joint genotypes.


Find Patent Forward Citations

Loading…